Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.27+0.52 (+1.25%)
At close: 04:00PM EDT
40.80 -1.47 (-3.48%)
After hours: 06:42PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
848,809
810,456
729,264
1,122,599
599,674
Cost of Revenue
14,219
10,842
11,947
4,384
1,820
Gross Profit
834,590
799,614
717,317
1,118,215
597,854
Operating Expenses
Research Development
706,230
643,453
535,077
465,688
414,604
Selling General and Administrative
136,600
170,900
354,300
286,644
244,622
Total Operating Expenses
842,830
814,353
889,377
752,332
659,226
Operating Income or Loss
-8,240
-14,739
-172,060
365,883
-61,372
Interest Expense
3,300
4,300
44,990
48,768
44,789
Total Other Income/Expenses Net
-8,714
-5,113
47,040
29,654
30,005
Income Before Tax
-25,807
-29,148
-170,032
346,769
-76,156
Income Tax Expense
2,346
-551
316,734
43,507
-291,141
Income from Continuing Operations
-28,153
-28,597
-486,766
303,262
214,985
Net Income
-28,153
-28,597
-451,286
294,146
273,741
Net Income available to common shareholders
-28,153
-28,597
-451,487
296,563
276,868
Basic EPS
-
-0.20
-3.23
2.12
2.09
Diluted EPS
-
-0.20
-3.23
2.08
2.07
Basic Average Shares
-
141,000
140,000
140,000
132,320
Diluted Average Shares
-
141,000
140,000
143,000
134,056
EBITDA
-
-5,288
-107,882
411,531
-18,839